# OnCo record paper-nct05101096-int-j-clin-oncol-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct05101096-int-j-clin-oncol-2024/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct05101096-int-j-clin-oncol-2024" ;
  schema:name "Preliminary results from ASCENT-J02: a phase 1/2 study of sacituzumab govitecan in Japanese patients with advanced solid tumors"@en ;
  schema:description "Published report from the ASCENT-J02 trial registered as NCT05101096, in International journal of clinical oncology (2024), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct05101096-int-j-clin-oncol-2024/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1007/s10147-024-02589-x>, <https://pubmed.ncbi.nlm.nih.gov/39302614/>, <https://europepmc.org/article/MED/39302614>, <https://clinicaltrials.gov/study/NCT05101096> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1007/s10147-024-02589-x> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Naito Y, Nakamura S, Kawaguchi-Sakita N, et al." ;
  onco:trials <https://onco.cc/trials/nct05101096/> ;
  onco:journals <https://onco.cc/journals/international-journal-of-clinical-oncology/> .
